Physician profile
James Burke
NPI 1003804980
$5,115.93
in general payments reported to CMS, 2019-2025
17 companies · $846 in 2025
The $846 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $279 · 2021: $565 · 2022: $531 · 2023: $1,546 · 2024: $503 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,746 · Travel and Lodging: $149.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,745.66 |
| Travel and Lodging | $149.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,686.33 | 2019-2025 | Impella |
| Boston Scientific Corporation | $628.77 | 2019-2025 | Avvigo Guidance System |
| Medtronic, INC. | $534.91 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abbott Laboratories | $513.66 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Impulse Dynamics (USA) INC. | $369.97 | 2023-2025 | Optimizer, Optimizer |
| Shockwave Medical, INC | $208.50 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $204.83 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $173.03 | 2023 | Everest Spinal System |
| E.R. Squibb & Sons, L.L.C. | $156.48 | 2021-2023 | Camzyos |
| Medtronic Vascular, INC. | $149.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $136.37 | 2019-2024 | |
| Chiesi USA, INC. | $95.99 | 2019-2023 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $69.61 | 2025 | |
| Janssen Pharmaceuticals, INC | $58.74 | 2021-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.11 | 2019-2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iovance Biotherapeutics, INC. | $40.80 | 2025 | Amtagvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.